Tyler J. S. Smith

Tyler J. S. Smith

Auto-generated profile, based on publicly available information

Tyler J. S. Smith

Department of Environmental Health & Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2022 in Current Environmental Health Reports
Verified
Journal Article
Closed access
PDF file
TSTyler J. S. Smith
Tyler J. S. Smith
AKAlexander P. Keil
Alexander P. Keil
JBJessie Buckley
Jessie Buckley

9 February 2023 in Paediatric and Perinatal Epidemiology
Verified
Journal Article
Open access
LALindsay N. Avolio
Lindsay N. Avolio
TSTyler J. S. Smith
Tyler J. S. Smith
ANAna Navas-Acien
Ana Navas-Acien
KKKate Kruczynski
Kate Kruczynski
NPNora Pisanic
Nora Pisanic
CHChristopher D. Heaney
Christopher D. Heaney
Background: Arsenic exposure and micronutrient deficiencies may alter immune reactivity to influenza vaccination in pregnant women, transplacental transfer of maternal antibodies to the foetus, and maternal and infant acute morbidity.Objectives: The Pregnancy, Arsenic, and Immune Response (PAIR) Study was designed to assess whether arsenic exposure and micronutrient deficiencies alter maternal and newborn immunity and acute morbidity following maternal seasonal influenza vaccination during pregnancy.Population: The PAIR Study recruited pregnant women across a large rural study area in Gaibandha District, northern Bangladesh, 2018–2019.Design: Prospective, longitudinal pregnancy and birth cohort.Methods: We conducted home visits to enrol pregnant women in the late first or early second trimester (11–17 weeks of gestational age). Women received a quadrivalent seasonal inactivated influenza vaccine at enrolment. Follow‐up included up to 13 visits between enrolment and 3 months postpartum. Arsenic was measured in drinking water and maternal urine. Micronutrient deficiencies were assessed using plasma biomarkers. Vaccine‐specific antibody titres were measured in maternal and infant serum. Weekly telephone surveillance ascertained acute morbidity symptoms in women and infants.Preliminary Results: We enrolled 784 pregnant women between October 2018 and March 2019. Of 784 women who enrolled, 736 (93.9%) delivered live births and 551 (70.3%) completed follow‐up visits to 3 months postpartum. Arsenic was detected (≥0.02 μg/L) in 99.7% of water specimens collected from participants at enrolment. The medians (interquartile ranges) of water and urinary arsenic at enrolment were 5.1 (0.5, 25.1) μg/L and 33.1 (19.6, 56.5) μg/L, respectively. Water and urinary arsenic were strongly correlated (Spearman's ⍴ = 0.72) among women with water arsenic ≥ median but weakly correlated (⍴ = 0.17) among women with water arsenic < median.Conclusions: The PAIR Study is well positioned to examine the effects of low‐moderate arsenic exposure and micronutrient deficiencies on immune outcomes in women and infants.Registration: NCT03930017.

19 June 2023 in Environmental Research
Verified
Journal Article
Open access
TSTyler J.S. Smith
Tyler J.S. Smith
ANAna Navas-Acien
Ana Navas-Acien
SBSarah Baker
Sarah Baker
CKCaryn Kok
Caryn Kok
KKKate Kruczynski
Kate Kruczynski
CHChristopher D. Heaney
Christopher D. Heaney
Arsenic methylation converts inorganic arsenic (iAs) to monomethyl (MMA) and dimethyl (DMA) arsenic compounds. Body mass index (BMI) has been positively associated with arsenic methylation efficiency (higher DMA%) in adults, but evidence in pregnancy is inconsistent. We estimated associations between anthropometric measures and arsenic methylation among pregnant women in rural northern Bangladesh. We enrolled pregnant women (n = 784) (median [IQR] gestational week: 14 [13, 15]) in Gaibandha District, Bangladesh from 2018 to 2019. Anthropometric measures were BMI, subscapular and triceps skinfold thicknesses, and mid-upper arm circumference (MUAC), fat area (MUAFA), and muscle area (MUAMA). Arsenic methylation measures were urinary iAs, MMA, and DMA divided by their sum and multiplied by 100 (iAs%, MMA%, and DMA%), primary methylation index (MMA/iAs; PMI), and secondary methylation index (DMA/MMA; SMI). In complete cases (n = 765 [97.6%]), we fitted linear, beta, and Dirichlet regression models to estimate cross-sectional differences in iAs%, MMA%, DMA%, PMI, and SMI per IQR-unit difference in each anthropometric measure, adjusting for drinking water arsenic, age, gestational age, education, living standards index, and plasma folate, vitamin B12, and homocysteine. Median (IQR) BMI, subscapular skinfold thickness, triceps skinfold thickness, MUAC, MUAFA, and MUAMA were 21.5 (19.4, 23.8) kg/m2, 17.9 (13.2, 24.2) mm, 14.2 (10.2, 18.7) mm, 25.9 (23.8, 28.0) cm, 15.3 (10.5, 20.3) cm2, and 29.9 (25.6, 34.2) cm2, respectively. Median (IQR) iAs%, MMA%, DMA%, PMI, and SMI were 12.0 (9.3, 15.2)%, 6.6 (5.3, 8.3)%, 81.0 (77.1, 84.6)%, 0.6 (0.4, 0.7), and 12.2 (9.3, 15.7), respectively. In both unadjusted and adjusted linear models, all anthropometric measures were negatively associated with iAs%, MMA%, and PMI and positively associated with DMA% and SMI. For example, fully adjusted mean differences (95% CI) in DMA% per IQR-unit difference in BMI, subscapular skinfolds thickness, triceps skinfold thickness, MUAC, MUAFA, and MUAMA were 1.72 (1.16, 2.28), 1.58 (0.95, 2.21), 1.74 (1.11, 2.37), 1.45 (0.85, 2.06), 1.70 (1.08, 2.31), and 0.70 (0.13, 1.27) pp, respectively. Anthropometric measures were positively associated with arsenic methylation efficiency among pregnant women in the early second trimester.

10 December 2025 in Current Developments in Nutrition
Verified
Journal Article
Open access
TSTyler Js Smith
Tyler Js Smith
HSHachem Saddiki
Hachem Saddiki
JBJoseph M Braun
Joseph M Braun
AMAmanda J MacFarlane
Amanda J MacFarlane
ELEric Lavigne
Eric Lavigne
Youssef OulhoteYoussef Oulhote
Youssef Oulhote
Folic acid (FA) has been reported to modify associations between air pollutants and autism, but no study has investigated whether air pollutants are associated with maternal folate status. We estimated associations between an air pollution mixture and maternal folate status among pregnant women in Canada. We enrolled pregnant women (n = 1983) in 10 cities in Canada from 2008 to 2011 in a prospective cohort. We estimated mean daily concentrations of nitrogen dioxide (NO2), ozone (O3), fine particulate matter (PM2.5), and sulfur dioxide (SO2) at maternal residences for 180 d preceding first and third trimester visits (ranges: 6–14 and 32–34 gestational weeks, respectively). At both visits, we measured plasma 5-methyltetrahydrofolate (5MTHF), unmetabolized FA (UMFA), and nonmethylated folate (NMF) concentrations and proportions (%5MTHF, %UMFA, %NMF). We used Bayesian weighted quantile sum regression to estimate expected differences in folate measures per 1-quartile difference in the air pollution mixture and weights for the mixture components. We stratified by fetal sex and FA supplementation. Among complete cases in the first and third trimesters (n = 927 and 838, respectively), median (interquartile range) plasma total folate was similar between the first trimester [96.9 (78.6, 119.0) nmol/L] and the third trimester [99.6 (76.0, 135.0) nmol/L]. In the third but not the first trimester, the mixture was positively associated with plasma total folate [12.0 nmol/L per one-quartile increase, 95% confidence interval (CI): 1.5, 22.7 nmol/L], negatively associated with %5MTHF (–2.8, 95% CI: –5.1, –0.70), and positively associated with %UMFA (13.4, 95% CI: 4.4, 23.0). O3 was the primary component (weights ≥0.4). Associations were stronger for women with female fetuses. Air pollution was positively associated with total folate concentrations and UMFA proportions and negatively associated with 5MTHF proportions. Associations were strongest in the third trimester and among pregnant women carrying female fetuses. Air pollution may influence maternal folate status during pregnancy.

5 April 2022 in medRxiv
Verified
Preprint
Open access
PDF file
LALindsay N. Avolio
Lindsay N. Avolio
TSTyler J. S. Smith
Tyler J. S. Smith
ANAna Navas-Acien
Ana Navas-Acien
KKKate Kruczynski
Kate Kruczynski
NPNora Pisanic
Nora Pisanic
NPNutrition Research Project
Nutrition Research Project
Purpose Arsenic exposure and micronutrient deficiencies may alter immune reactivity to influenza vaccination in pregnant women, transplacental transfer of maternal antibodies to the fetus, and maternal and infant acute morbidity. The Pregnancy, Arsenic, and Immune Response (PAIR) Study is a longitudinal pregnancy and birth cohort designed to assess whether arsenic exposure and micronutrient deficiencies alter maternal or newborn immunity and acute morbidity following maternal seasonal influenza vaccination during pregnancy. Participants We enrolled 784 pregnant women in rural Gaibandha District in northern Bangladesh between October 2018 and March 2019. Women received a quadrivalent seasonal inactivated influenza vaccine at enrollment in the late first or early second trimester between 11 and 17 weeks of gestational age. Follow-up included up to 13 visits between enrollment and three months postpartum as well as weekly telephone surveillance to ascertain influenza-like illness and other acute morbidity symptoms in women and infants. Tube well drinking water and urine specimens were collected to assess arsenic exposure. Of 784 women who enrolled, 736 (93.9%) delivered live births and 551 (70.3%) completed follow-up visit to three months postpartum. Findings to Date Arsenic was ≥0.02 µg/L in 97.9% of water specimens collected from participants at enrollment. The medians (interquartile ranges) of water and urinary arsenic were 5.1 (0.5-25.1) µg/L and 33.1 (19.6-56.5) µg/L, respectively. Water and urinary arsenic were strongly correlated (Spearman’s ρ=0.72) among women with water arsenic ≥ median but weakly correlated (ρ=0.18) among women with water arsenic < median. Future Plans The PAIR Study is well positioned to examine the effects of low-moderate arsenic exposure and micronutrient deficiencies on immune outcomes in women and infants. Registration NCT03930017